Cargando…
Overexpression of EphB2 in hippocampus rescues impaired NMDA receptors trafficking and cognitive dysfunction in Alzheimer model
Alzheimer's disease (AD) is a progressive neurodegenerative disease, which affects more and more people. But there is still no effective treatment for preventing or reversing the progression of the disease. Soluble amyloid-beta (Aβ) oligomers, also known as Aβ-derived diffusible ligands (ADDLs)...
Autores principales: | Hu, Rui, Wei, Pan, Jin, Lu, Zheng, Teng, Chen, Wen-Yu, Liu, Xiao-Ya, Shi, Xiao-Dong, Hao, Jing-Ru, Sun, Nan, Gao, Can |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386541/ https://www.ncbi.nlm.nih.gov/pubmed/28358367 http://dx.doi.org/10.1038/cddis.2017.140 |
Ejemplares similares
-
Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion
por: Lee, Tae Ho, et al.
Publicado: (2021) -
Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus
por: Henkemeyer, Mark, et al.
Publicado: (2003) -
EphB2: potential therapeutic target for Alzheimer’s disease
Publicado: (2011) -
EphB6 overexpression and Apc mutation together promote colorectal cancer
por: Xu, Dan, et al.
Publicado: (2016) -
Spinal ephrinB/EphB signalling contributed to remifentanil-induced hyperalgesia via NMDA receptor
por: Xia, WS, et al.
Publicado: (2014)